1. Home
  2. IMNM vs TRTX Comparison

IMNM vs TRTX Comparison

Compare IMNM & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • TRTX
  • Stock Information
  • Founded
  • IMNM 2006
  • TRTX 2014
  • Country
  • IMNM United States
  • TRTX United States
  • Employees
  • IMNM N/A
  • TRTX N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • TRTX Real Estate Investment Trusts
  • Sector
  • IMNM Health Care
  • TRTX Real Estate
  • Exchange
  • IMNM Nasdaq
  • TRTX Nasdaq
  • Market Cap
  • IMNM 770.1M
  • TRTX 580.6M
  • IPO Year
  • IMNM 2020
  • TRTX 2017
  • Fundamental
  • Price
  • IMNM $7.46
  • TRTX $7.67
  • Analyst Decision
  • IMNM Strong Buy
  • TRTX Strong Buy
  • Analyst Count
  • IMNM 5
  • TRTX 4
  • Target Price
  • IMNM $26.40
  • TRTX $9.50
  • AVG Volume (30 Days)
  • IMNM 1.1M
  • TRTX 703.9K
  • Earning Date
  • IMNM 05-16-2025
  • TRTX 04-29-2025
  • Dividend Yield
  • IMNM N/A
  • TRTX 12.52%
  • EPS Growth
  • IMNM N/A
  • TRTX N/A
  • EPS
  • IMNM N/A
  • TRTX 0.70
  • Revenue
  • IMNM $9,041,000.00
  • TRTX $148,005,000.00
  • Revenue This Year
  • IMNM N/A
  • TRTX N/A
  • Revenue Next Year
  • IMNM $1,259.12
  • TRTX $7.24
  • P/E Ratio
  • IMNM N/A
  • TRTX $10.98
  • Revenue Growth
  • IMNM N/A
  • TRTX N/A
  • 52 Week Low
  • IMNM $5.15
  • TRTX $6.47
  • 52 Week High
  • IMNM $19.07
  • TRTX $9.66
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 43.56
  • TRTX 53.83
  • Support Level
  • IMNM $7.15
  • TRTX $7.47
  • Resistance Level
  • IMNM $9.16
  • TRTX $7.74
  • Average True Range (ATR)
  • IMNM 0.51
  • TRTX 0.19
  • MACD
  • IMNM -0.08
  • TRTX 0.07
  • Stochastic Oscillator
  • IMNM 15.42
  • TRTX 88.16

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.

Share on Social Networks: